Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22789,97,1.03 [0.78-1.35],0.8437367277843729
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23413,178,0.81 [0.63-1.04],0.1024137199683646
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23185,1137,1.03 [0.95-1.12],0.4237777651434918
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Candidiasis,23444,408,1.01 [0.88-1.15],0.9343357804561456
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22711,2985,1.03 [0.98-1.08],0.2427443474203306
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22910,2418,1.03 [0.98-1.09],0.255419203326675
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23197,1140,1.02 [0.95-1.11],0.5383406514588631
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23340,79,0.51 [0.31-0.86],0.0115766969539717
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21891,685,1.07 [0.97-1.18],0.17020524678998
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21143,784,1.04 [0.95-1.15],0.3586438854326708
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21201,218,1.03 [0.86-1.24],0.7254092908748244
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16435,1389,1.07 [1.00-1.15],0.0426897266870276
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21008,313,1.09 [0.95-1.26],0.2109997962842722
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23381,1324,0.99 [0.92-1.07],0.8786715854501174
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Mycoses,23495,459,1.00 [0.88-1.14],0.991648456793368
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22850,802,1.01 [0.92-1.11],0.8111441608004264
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23444,752,1.07 [0.97-1.17],0.178732733388945
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22235,178,0.81 [0.63-1.04],0.1030510208842114
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23548,35,1.15 [0.79-1.68],0.4695412197920258
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23356,664,1.08 [0.99-1.19],0.0983016370236821
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23336,75,0.86 [0.59-1.25],0.4253463482187123
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23463,164,1.10 [0.91-1.32],0.350445806791536
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23449,150,1.10 [0.90-1.34],0.3583071342003695
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22338,290,0.99 [0.84-1.17],0.923443342674042
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22270,222,1.12 [0.96-1.32],0.1587849828408414
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22153,96,0.74 [0.51-1.07],0.113275082578945
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23525,33,1.08 [0.70-1.67],0.7239662521651207
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23484,141,1.10 [0.90-1.35],0.3556679785948496
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral warts,23384,41,1.19 [0.85-1.68],0.3076117261297452
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23414,71,0.97 [0.69-1.36],0.8635246867686278
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm,23317,201,1.14 [0.96-1.34],0.1262271937399789
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23460,57,1.18 [0.88-1.58],0.2577553998560454
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23455,58,1.00 [0.69-1.43],0.9807052034821624
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23300,1042,1.01 [0.93-1.10],0.8277722742511735
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of meninges,23524,72,0.87 [0.60-1.26],0.460194199318794
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23489,57,0.95 [0.64-1.39],0.7752043258545819
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23518,107,1.09 [0.86-1.39],0.4602932118973456
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of ovary,23480,148,0.82 [0.62-1.08],0.1550696557245929
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23528,235,0.93 [0.77-1.13],0.460233952139409
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Caecum,23534,214,1.06 [0.89-1.26],0.5200296094605592
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23468,54,0.94 [0.63-1.40],0.7670284574796772
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Descending colon,23533,131,1.13 [0.92-1.39],0.2370259839949966
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Rectum,23494,239,1.10 [0.94-1.28],0.243603619509511
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23452,437,1.02 [0.90-1.16],0.7384179022831097
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23534,252,0.98 [0.82-1.17],0.8070196541885546
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Carcinoma in situ of breast,19054,119,0.63 [0.43-0.91],0.0149916100453221
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19126,138,0.70 [0.51-0.97],0.0329401308684767
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19121,30,1.03 [0.64-1.66],0.910139707893165
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19147,56,0.73 [0.45-1.20],0.2199138554674239
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23484,124,1.20 [0.99-1.45],0.0613152786034547
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Haemangioma, any site",23485,122,1.20 [0.99-1.45],0.0652358785096701
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Leiomyoma of uterus,22685,498,0.93 [0.82-1.06],0.2931566691737636
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Lung cancer and mesothelioma,16927,277,1.06 [0.91-1.24],0.4481244634840426
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Lymphoid leukaemia,19125,34,0.93 [0.56-1.54],0.7860001778589867
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19243,152,1.01 [0.82-1.26],0.9042402633404402
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19186,95,0.78 [0.54-1.12],0.1723550162552761
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19251,160,1.04 [0.85-1.28],0.6906416151768975
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19152,61,0.89 [0.60-1.32],0.5689657290798273
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19152,61,0.71 [0.44-1.16],0.1700993986832016
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19137,46,1.16 [0.84-1.59],0.3723338416449241
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19220,129,1.08 [0.88-1.34],0.454623848047614
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19180,89,0.71 [0.48-1.07],0.1001840088859594
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19162,71,0.97 [0.70-1.35],0.8614725176925413
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19126,35,1.28 [0.92-1.77],0.1432115078329799
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19160,69,0.97 [0.69-1.36],0.846010968742215
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanocytic naevi,23318,195,1.18 [1.01-1.38],0.0351978559719469
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanocytic naevi of trunk,23508,66,1.29 [1.03-1.64],0.030179746456543
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanoma in situ,19119,72,1.19 [0.92-1.53],0.1853808101372524
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19161,70,0.93 [0.66-1.33],0.6973131485285022
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19219,128,1.04 [0.82-1.30],0.767628239959545
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19293,202,1.03 [0.86-1.23],0.7473765221573716
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19171,80,0.95 [0.69-1.31],0.7494759226996413
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Other benign neoplasms of skin,23351,151,0.98 [0.79-1.23],0.8914459826012932
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19884,793,1.04 [0.95-1.14],0.4051881998570475
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19918,827,1.03 [0.94-1.13],0.5307389516393948
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23273,336,1.01 [0.87-1.17],0.9192406873041754
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21837,84,0.97 [0.72-1.32],0.8670642345365115
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23007,70,0.96 [0.68-1.35],0.803802323337878
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22681,2535,1.02 [0.97-1.07],0.4890818664970643
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22166,27,0.75 [0.37-1.51],0.4264438833500766
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23207,43,1.07 [0.73-1.58],0.7180337661779874
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23046,1293,1.03 [0.95-1.11],0.4778894609548022
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23046,1293,1.03 [0.95-1.11],0.4778894609548022
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21820,67,1.06 [0.78-1.45],0.6942186385061004
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23192,1053,1.05 [0.97-1.14],0.1865950466531115
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23264,100,1.15 [0.91-1.45],0.2316980108564844
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22982,45,1.03 [0.70-1.52],0.8835490586940237
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22988,51,0.82 [0.51-1.31],0.4051640280858931
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23365,201,0.92 [0.75-1.14],0.4500355291861825
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23455,51,0.87 [0.56-1.36],0.5439984920420051
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23337,173,0.93 [0.74-1.17],0.5290890397982748
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22253,114,1.10 [0.88-1.38],0.4153810873804939
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18991,202,0.98 [0.81-1.19],0.8529645501669608
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22322,57,0.84 [0.54-1.29],0.4250878886624697
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22318,53,1.00 [0.69-1.45],0.9897343233826592
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18832,43,1.28 [0.95-1.72],0.1001595793911475
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21590,55,0.88 [0.58-1.34],0.5445299049027166
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21313,205,0.96 [0.79-1.18],0.713722006730224
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23174,411,1.00 [0.87-1.14],0.9567948604196548
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23018,255,0.82 [0.66-1.01],0.0644886005152775
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22824,61,0.90 [0.61-1.34],0.6139350258130376
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23217,1682,0.89 [0.83-0.96],0.0031408225952695
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20882,1643,0.89 [0.83-0.96],0.0037631481859057
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18833,44,1.03 [0.69-1.53],0.8881245735900759
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20937,99,0.91 [0.67-1.23],0.5336455496469679
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19025,236,1.12 [0.96-1.30],0.1508019074993738
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18830,41,1.08 [0.73-1.59],0.7060360505852766
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21478,2689,0.96 [0.91-1.02],0.1703493595175066
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18971,182,1.14 [0.97-1.35],0.1163971106913093
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19252,463,1.09 [0.98-1.22],0.12033139661909
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23464,303,0.91 [0.76-1.08],0.2813913855919526
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23302,141,1.04 [0.83-1.29],0.756922623719255
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18878,89,0.59 [0.37-0.92],0.0206322359134436
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18839,50,1.16 [0.85-1.59],0.3534778479236252
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22793,1955,0.96 [0.90-1.03],0.2765978200704195
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18959,170,1.07 [0.88-1.29],0.4997716362734901
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18957,168,1.09 [0.90-1.31],0.3720239960344023
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19246,457,1.04 [0.92-1.17],0.5625637319868368
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18857,68,0.92 [0.64-1.31],0.6367269170554011
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23297,136,1.03 [0.82-1.29],0.8135657996805261
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19319,530,1.00 [0.89-1.12],0.9580095527194356
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19262,473,0.91 [0.79-1.05],0.1810286556572168
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21171,63,0.95 [0.66-1.37],0.7875945050901323
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22799,4010,0.98 [0.94-1.02],0.3743054449839281
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20901,63,0.78 [0.50-1.21],0.2741833829755077
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20913,75,1.22 [0.96-1.55],0.0987379908476494
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23380,1758,0.98 [0.92-1.05],0.5993558445407206
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23384,1757,0.98 [0.92-1.06],0.6596398100443788
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20912,74,0.99 [0.72-1.36],0.9393168252129308
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23191,1353,0.90 [0.83-0.98],0.0149647370898856
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20061,1272,0.98 [0.91-1.06],0.6365969621898119
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23538,154,0.98 [0.78-1.23],0.8747880499504912
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22801,38,1.34 [1.00-1.79],0.0464398692523249
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21955,117,1.06 [0.84-1.34],0.6050164149085849
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22006,168,1.23 [1.05-1.44],0.0115595907472274
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19003,214,1.11 [0.95-1.31],0.1972622327013918
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21981,120,1.11 [0.89-1.38],0.3721225247448247
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1465,37,0.74 [0.42-1.30],0.292359249993488
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1557,147,1.13 [0.92-1.38],0.2529432017360791
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21886,25,0.87 [0.46-1.62],0.6546211126871749
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1450,23,0.89 [0.46-1.73],0.7383222065078001
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23143,1282,0.97 [0.90-1.05],0.4577147934079451
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23050,287,0.99 [0.84-1.16],0.8780324877400008
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21515,407,0.97 [0.84-1.12],0.655458454406662
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19394,605,0.86 [0.75-0.98],0.0233812664608643
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23463,205,0.99 [0.82-1.20],0.9125481478471376
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22673,42,1.18 [0.84-1.64],0.338725262445728
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Angina pectoris,22242,744,0.98 [0.89-1.09],0.7521505027719053
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22709,78,1.12 [0.86-1.45],0.4163742298692643
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22661,30,1.07 [0.68-1.69],0.7614940202055845
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22769,138,0.97 [0.77-1.23],0.8234975232210064
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15291,1234,0.97 [0.89-1.05],0.4514850569135838
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,AV-block,20661,205,0.93 [0.76-1.15],0.52246285135121
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23506,265,1.01 [0.85-1.19],0.926766612970325
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cardiac arrest,14162,105,0.98 [0.75-1.29],0.904752943256954
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20570,114,1.00 [0.78-1.29],0.9765877652598406
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20525,69,1.11 [0.83-1.48],0.4712807976142191
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23544,27,0.69 [0.33-1.47],0.3401798767779285
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Conduction disorders,21075,619,0.94 [0.84-1.06],0.2995294585566329
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22762,1275,0.99 [0.92-1.07],0.8003853925444326
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21196,6248,0.97 [0.94-1.01],0.1309632100179368
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22270,218,1.00 [0.83-1.21],0.9894685732810594
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Endocarditis,20502,46,0.90 [0.58-1.41],0.6591432491518137
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23462,714,0.99 [0.90-1.10],0.9014475085215282
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypertension,21731,5263,0.97 [0.93-1.01],0.11526106231309
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21740,5272,0.97 [0.93-1.01],0.1155943148921194
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23449,36,1.15 [0.79-1.68],0.4695623815182298
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16614,146,0.92 [0.71-1.18],0.4910824365115476
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16533,65,0.93 [0.64-1.34],0.6826984778708373
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypotension,23431,909,1.01 [0.92-1.10],0.9105611236753312
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22898,80,1.08 [0.82-1.43],0.5709346656945024
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22942,1444,0.98 [0.91-1.05],0.5800561463335028
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23277,391,0.96 [0.83-1.11],0.5499985360641468
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20721,265,1.06 [0.90-1.23],0.4993274978228894
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23361,519,1.04 [0.93-1.17],0.4687570098798836
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21913,415,1.03 [0.90-1.17],0.6739974072121309
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23523,76,0.88 [0.62-1.26],0.4850927797718138
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23540,207,1.04 [0.87-1.25],0.6327361429103266
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Oesophageal varices,22085,33,1.19 [0.80-1.76],0.3958979800240896
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other aneurysm,22680,49,1.22 [0.91-1.63],0.1864184647961361
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other arrhythmias,20770,314,1.08 [0.94-1.24],0.291797299467562
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22691,60,1.03 [0.74-1.44],0.8396916886277039
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22799,168,1.09 [0.91-1.31],0.3615191920703826
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20601,145,1.06 [0.86-1.31],0.5577336949942842
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other disorders of veins,22125,73,0.79 [0.52-1.19],0.2611350772787701
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22093,41,0.75 [0.42-1.32],0.3201604772908493
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22481,30,0.54 [0.24-1.22],0.1365989764100942
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22186,134,1.03 [0.82-1.30],0.7935856074652489
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21119,663,1.02 [0.92-1.13],0.6726499079397152
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22558,36,1.33 [0.97-1.82],0.0761119930325725
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23066,435,0.98 [0.85-1.12],0.7209675067819472
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23047,277,1.00 [0.85-1.17],0.9759963231595172
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22909,458,1.01 [0.89-1.15],0.8382232307991367
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14305,248,1.03 [0.87-1.22],0.7235507876016942
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22862,242,0.98 [0.82-1.17],0.8204121236827518
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22338,286,1.04 [0.89-1.21],0.6581660880149325
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23149,379,0.98 [0.85-1.13],0.8090413263978313
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23477,489,1.00 [0.88-1.13],0.998621609644097
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20638,182,0.96 [0.78-1.19],0.7308974512350759
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23040,270,1.01 [0.86-1.19],0.8903347029018203
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22581,130,1.15 [0.94-1.40],0.1854468871785254
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23268,450,0.97 [0.85-1.11],0.6905992704069188
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23243,489,0.98 [0.86-1.11],0.7501568085224005
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22865,58,1.03 [0.73-1.45],0.8663500927383057
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22668,37,1.09 [0.73-1.62],0.6761425079510789
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23069,183,0.95 [0.77-1.18],0.6298247729173531
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23015,173,1.05 [0.86-1.27],0.643293349810313
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Varicose veins,22432,380,1.01 [0.88-1.16],0.8853694971399142
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22640,80,0.92 [0.66-1.29],0.634542925586016
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23365,602,1.00 [0.90-1.12],0.9640097015259628
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23511,188,1.02 [0.84-1.24],0.8114913127705053
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20923,1579,0.93 [0.86-1.00],0.0590439703736631
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Any mental disorder,23031,3687,0.94 [0.90-0.99],0.0152403014684032
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23486,223,0.98 [0.82-1.18],0.863935390876651
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21042,1698,0.89 [0.83-0.96],0.0023549469762168
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19423,79,1.06 [0.80-1.41],0.6839191050678518
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Smoking dependency,23200,1024,1.01 [0.92-1.10],0.8600287160860227
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20531,1187,0.98 [0.91-1.07],0.6917187254503596
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Vascular dementia,23129,90,0.54 [0.34-0.87],0.0110350086394985
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Alzheimer disease,23546,317,0.81 [0.67-0.98],0.0312296604442115
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16123,49,0.80 [0.48-1.34],0.4066647734165328
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Bell's palsy,21703,68,0.87 [0.60-1.28],0.4946104288916735
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22191,556,0.97 [0.86-1.10],0.6636494361551206
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Cerebral cysts,23202,180,0.97 [0.79-1.20],0.7848282909050655
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23482,233,0.97 [0.80-1.16],0.722575635885871
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23132,39,0.51 [0.25-1.07],0.0760275662828672
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23535,43,1.20 [0.87-1.67],0.271091358185406
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23064,42,0.82 [0.49-1.38],0.4592923559112415
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Epilepsy,22289,242,0.94 [0.77-1.13],0.5014630064559077
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23182,1135,0.96 [0.88-1.05],0.3434608221233138
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23503,307,0.97 [0.82-1.14],0.6763046843862558
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23014,2472,1.00 [0.95-1.06],0.9909860100232284
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Generalized epilepsy,23236,41,0.75 [0.42-1.32],0.3180456296185449
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Hemiplegia,23434,185,1.05 [0.87-1.27],0.6093377080107113
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Hydrocephalus,23077,55,0.78 [0.48-1.25],0.3005805210949359
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23528,66,0.82 [0.54-1.24],0.3364979820669849
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21745,110,1.15 [0.92-1.43],0.2197084309384329
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21688,53,1.20 [0.90-1.60],0.2150243582542216
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Memory loss,23021,91,1.09 [0.84-1.40],0.5174068997617983
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Migraine,22486,439,0.96 [0.83-1.10],0.5191821611751077
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23445,398,0.99 [0.87-1.14],0.9230387978704446
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Motor neuron disease,16214,116,1.12 [0.89-1.40],0.3313373406886103
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23348,124,0.85 [0.63-1.13],0.260470693620707
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22835,1200,0.96 [0.89-1.05],0.3605188075524008
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Neurological diseases,22154,3176,0.97 [0.92-1.02],0.2358779718546776
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23216,123,1.04 [0.82-1.31],0.7691105804326027
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22000,365,1.02 [0.89-1.18],0.7555267544615816
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23495,191,0.95 [0.77-1.18],0.6596307166945787
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19039,569,0.83 [0.72-0.96],0.0098388580032138
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23079,57,0.81 [0.51-1.27],0.3527993189907912
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23131,109,0.89 [0.66-1.20],0.442716780403308
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23336,140,0.87 [0.66-1.14],0.3030934768774798
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21711,76,0.95 [0.68-1.33],0.7730430426160717
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other headache syndromes,22111,64,0.75 [0.47-1.18],0.2113585342831061
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other neurological diseases,23446,424,0.92 [0.80-1.07],0.2850541135349429
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other sleep disorders,22389,342,1.00 [0.86-1.17],0.9962665086341936
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Parkinson's disease,23523,146,1.02 [0.82-1.28],0.8404528671608253
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23091,69,0.98 [0.70-1.38],0.9268700983594358
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Restless leg syndrome,23545,75,0.71 [0.46-1.09],0.1193260651408827
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Sleep apnoea,23393,275,1.04 [0.88-1.23],0.6340630205791733
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23338,34,1.00 [0.63-1.60],0.9862958596490096
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23536,141,1.05 [0.85-1.30],0.6503937997778082
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21693,58,0.72 [0.44-1.18],0.1929632199661901
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23546,320,0.81 [0.67-0.98],0.034057938281814
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23089,87,0.53 [0.33-0.87],0.0116918400451855
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23042,91,0.88 [0.63-1.22],0.44294540913161
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23155,411,0.90 [0.77-1.05],0.177182227300757
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23422,138,1.10 [0.89-1.35],0.392781248414777
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22585,52,0.90 [0.59-1.38],0.6418442366060345
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22580,47,0.72 [0.42-1.24],0.2403423943611653
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23440,55,1.24 [0.94-1.63],0.1312274517456518
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23304,143,1.02 [0.81-1.27],0.8945667308209729
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1456,28,0.93 [0.53-1.66],0.8140385844134584
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1741,54,0.69 [0.41-1.16],0.164145750843743
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23033,82,1.10 [0.84-1.43],0.483076653572745
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23399,893,0.94 [0.86-1.04],0.2449508327112102
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23178,645,1.05 [0.95-1.16],0.3472305277500007
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22794,261,1.12 [0.97-1.30],0.1215752332949386
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23472,728,0.95 [0.85-1.05],0.3060307661942651
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23535,63,0.83 [0.54-1.26],0.3747525292812108
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23406,662,0.91 [0.81-1.02],0.1160215984057998
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23510,349,1.09 [0.95-1.24],0.2196141224792095
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23463,178,0.91 [0.72-1.14],0.4151254381040591
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22569,36,1.36 [1.00-1.84],0.0481303994012279
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22573,40,0.93 [0.59-1.49],0.77530042230283
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22595,62,0.67 [0.40-1.11],0.1162911953989368
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23468,613,0.98 [0.88-1.10],0.7514220490888333
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23004,149,0.91 [0.71-1.17],0.4636270184939123
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22800,56,0.88 [0.58-1.34],0.560009676440194
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23247,86,0.94 [0.69-1.29],0.7108222458216157
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23434,273,1.13 [0.99-1.31],0.077789993167791
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22924,180,0.94 [0.76-1.17],0.6065755630618914
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23401,116,0.94 [0.71-1.23],0.6367073048569056
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23254,399,0.95 [0.82-1.10],0.4788855455710537
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23083,132,1.01 [0.79-1.27],0.9643546597845134
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22004,2181,1.06 [1.01-1.13],0.0254478533066625
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23400,239,1.09 [0.93-1.28],0.2711820557457289
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23526,139,0.98 [0.78-1.24],0.8761322701632036
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22865,332,0.97 [0.83-1.14],0.744446607078677
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23219,58,0.99 [0.69-1.42],0.9573279115843596
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23521,49,0.88 [0.56-1.38],0.5761825336107327
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22613,80,0.99 [0.73-1.36],0.9619228685464872
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22661,128,0.85 [0.64-1.14],0.2735527284690602
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22595,89,1.03 [0.78-1.35],0.8604013623313589
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22800,56,1.30 [1.01-1.67],0.0431402939496439
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22561,55,0.61 [0.35-1.07],0.0861208489226872
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22958,103,1.02 [0.79-1.33],0.8750096540051828
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23010,155,0.94 [0.75-1.19],0.632994424502576
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22643,110,1.23 [1.00-1.50],0.0473725094951446
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22585,79,0.84 [0.58-1.21],0.353414035868457
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22563,57,0.83 [0.54-1.29],0.4154194324132509
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21612,1789,1.00 [0.94-1.07],0.9955602678781214
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22608,75,1.23 [0.97-1.56],0.093559382468025
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23321,370,0.94 [0.81-1.10],0.437337971650608
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22992,41,0.88 [0.53-1.44],0.6000529445408685
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23097,146,0.87 [0.67-1.13],0.3070908757223601
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23325,98,0.89 [0.65-1.22],0.4582459071998445
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23505,94,1.06 [0.81-1.38],0.6679810606430314
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23441,124,0.85 [0.64-1.14],0.2899302720791006
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23291,64,0.85 [0.56-1.27],0.4251922764970016
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23294,67,0.91 [0.63-1.32],0.6277902243286642
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23455,690,0.91 [0.81-1.02],0.1204731890560272
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23234,469,0.99 [0.87-1.12],0.8759952506928821
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22866,101,0.79 [0.56-1.12],0.1888763336909011
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22839,74,0.89 [0.62-1.28],0.5281118807746853
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute pharyngitis,23302,73,0.87 [0.60-1.26],0.4671770490289262
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23438,209,0.89 [0.72-1.11],0.294205930911697
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23287,58,0.87 [0.58-1.33],0.5275410748425603
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,All influenza,22103,112,1.06 [0.84-1.35],0.6071890551251585
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22102,111,1.07 [0.85-1.36],0.5583152572028041
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16763,113,1.02 [0.79-1.31],0.9019761474839076
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Allergic rhinitis,23425,246,0.98 [0.82-1.17],0.8412450899170825
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18285,1795,1.02 [0.96-1.09],0.5195638063238375
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18421,1771,1.03 [0.97-1.10],0.3287617235899834
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23190,115,0.95 [0.72-1.25],0.7128081302815261
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22051,60,0.88 [0.59-1.33],0.5566742549124457
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Bronchiectasis,20340,341,1.05 [0.91-1.21],0.4886299934563952
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20059,60,1.06 [0.76-1.48],0.7374863112347501
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22554,2555,1.03 [0.98-1.08],0.3025346871730133
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22442,57,0.67 [0.39-1.12],0.1281460357275285
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Chronic sinusitis,22511,126,0.89 [0.67-1.17],0.3947706024106185
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23398,889,1.00 [0.91-1.09],0.9393883847236292
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Deviated nasal septum,22450,65,0.64 [0.39-1.06],0.0806075570145804
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21752,4396,0.99 [0.95-1.03],0.6928840472165851
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22678,293,1.00 [0.86-1.18],0.9529196836143796
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Early onset COPD,22782,273,0.97 [0.81-1.16],0.739903332900719
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Emphysema,20226,227,1.12 [0.96-1.31],0.1345643041862655
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22088,200,1.06 [0.89-1.27],0.5055686319215169
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23374,1383,1.01 [0.94-1.08],0.8644812130307197
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Interstitial lung disease,22123,235,1.01 [0.85-1.21],0.8668672093075458
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Later onset COPD,22756,616,1.01 [0.90-1.12],0.9053804393356292
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23540,185,1.00 [0.82-1.22],0.987565350627762
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Nasal polyp,22443,58,0.93 [0.63-1.37],0.7115988703784837
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23347,792,0.99 [0.90-1.09],0.8535182385030716
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other diseases of pleura,23384,1489,1.02 [0.95-1.09],0.6335835585913344
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23067,682,0.97 [0.87-1.08],0.6299991840138782
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other pleural conditions,21929,34,0.67 [0.34-1.32],0.242585720562611
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23471,297,0.98 [0.84-1.15],0.8332156823177176
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23467,1014,1.01 [0.93-1.10],0.8529070858785819
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pleural effusion,22597,702,1.07 [0.98-1.18],0.1462587090977593
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pleural plaque,21938,43,1.14 [0.81-1.61],0.4538366997946845
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23166,1175,0.98 [0.90-1.06],0.630145966618097
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23514,159,0.96 [0.76-1.20],0.6936369360862384
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pneumothorax,21982,87,0.98 [0.74-1.31],0.9160296294685826
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pollen allergy,23521,207,0.99 [0.82-1.20],0.9589355215472684
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pulmonary oedema,23227,53,0.67 [0.39-1.15],0.1503752468176546
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16693,43,1.35 [1.01-1.82],0.0456001244049182
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23328,773,0.99 [0.90-1.09],0.871641387764369
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22631,246,0.98 [0.82-1.17],0.8277832203530042
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Viral pneumonia,22173,182,1.10 [0.92-1.33],0.2892590537826052
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23196,142,1.17 [0.97-1.42],0.102459249463989
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11349,90,1.19 [0.94-1.52],0.1515463588254051
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16830,34,1.27 [0.92-1.77],0.1517447981745563
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute appendicitis,23378,115,1.01 [0.79-1.30],0.9397568767971026
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute gastritis,17701,74,0.87 [0.61-1.26],0.4707967834020569
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute pancreatitis,21586,140,0.92 [0.71-1.19],0.523326343945342
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute peritonitis,23062,72,0.98 [0.71-1.36],0.9029818840006127
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22817,31,1.14 [0.75-1.74],0.540002819545506
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Barrett oesophagus,17918,291,0.90 [0.75-1.08],0.2550246299807807
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21513,67,0.92 [0.64-1.33],0.6540137295810223
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23188,67,0.91 [0.63-1.32],0.6322839373551348
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Cholecystitis,21598,152,0.94 [0.74-1.20],0.6300541349015841
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Cholelithiasis,22480,1034,1.03 [0.95-1.12],0.4400589135760314
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Chronic gastritis,17917,290,1.04 [0.90-1.21],0.5895174062078428
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21482,36,1.20 [0.84-1.72],0.3061536557311022
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23477,64,1.11 [0.82-1.50],0.4932612891381172
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Coeliac disease,22232,124,1.05 [0.84-1.32],0.652097751649728
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Collagenous colitis,21924,89,1.00 [0.75-1.33],0.9963139704217174
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23425,140,0.98 [0.78-1.24],0.8932404235806664
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Constipation,23252,1456,0.98 [0.91-1.05],0.5368146827437317
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Crohn disease,21906,71,0.76 [0.49-1.16],0.1957883273373117
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23238,49,0.73 [0.43-1.24],0.2453831387699761
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21909,74,0.83 [0.57-1.22],0.3476040906229485
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Dental caries,22834,197,0.95 [0.78-1.17],0.6457221565883458
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22148,2091,0.97 [0.92-1.03],0.3839845793458271
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of appendix,23415,152,0.93 [0.73-1.18],0.5458666396102301
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of liver,23462,676,0.95 [0.84-1.06],0.3270049283845497
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21569,3942,0.97 [0.93-1.02],0.2505096394890361
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23141,504,0.98 [0.86-1.11],0.7002246724041219
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23437,447,0.98 [0.86-1.12],0.7942634067099985
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22735,98,0.95 [0.71-1.28],0.7456303890484388
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22608,55,0.65 [0.38-1.12],0.1233854013105619
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23292,1184,0.95 [0.87-1.03],0.2174066377849362
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of tongue,22614,88,0.84 [0.59-1.19],0.3340305375872359
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22816,1370,1.02 [0.95-1.10],0.6289090882710157
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19548,2752,0.99 [0.94-1.05],0.8498787036769444
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Duodenal ulcer,17742,115,0.96 [0.74-1.25],0.7727085163556873
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23497,95,0.90 [0.65-1.23],0.5060526998045313
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23463,55,0.95 [0.64-1.39],0.7795164078628197
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22867,81,1.20 [0.95-1.53],0.1234013164655129
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16898,102,0.99 [0.76-1.30],0.9486398743348164
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Functional dyspepsia,18200,573,0.94 [0.83-1.06],0.3049213246932935
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastric ulcer,17926,299,1.03 [0.88-1.20],0.7246050163874473
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20002,2375,0.96 [0.91-1.02],0.190626361981644
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18040,413,1.01 [0.89-1.16],0.8306226327339861
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18412,7211,1.01 [0.98-1.04],0.657867015753539
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,GI-bleeding,23053,945,0.96 [0.88-1.05],0.394434533868262
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22697,60,1.17 [0.88-1.56],0.2792668748401573
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17639,1094,1.00 [0.92-1.09],0.9833046419793297
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22817,31,1.16 [0.77-1.74],0.4816496668175802
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Hernia,22529,2472,0.99 [0.94-1.05],0.8502942280981647
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Impacted teeth,23471,50,0.95 [0.63-1.42],0.7886722504340797
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Impaction of intestines,16856,60,0.91 [0.61-1.35],0.6401893333607951
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Inguinal hernia,20202,145,1.12 [0.92-1.36],0.2473621030749223
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16877,81,0.93 [0.67-1.29],0.6581229060221774
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22258,150,0.98 [0.78-1.23],0.8648280629801459
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17486,690,0.93 [0.83-1.04],0.2317619978621279
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23537,296,0.91 [0.77-1.09],0.3188799494078266
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22528,693,1.01 [0.92-1.12],0.8019251507690669
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22767,932,0.96 [0.87-1.05],0.3817186970979991
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17756,129,1.03 [0.82-1.30],0.8164840189345357
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oesophagitis,18113,486,1.00 [0.88-1.13],0.9830523681968198
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23505,136,1.09 [0.89-1.34],0.4065158324727241
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20109,52,0.89 [0.58-1.36],0.587753002679515
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17876,1080,0.94 [0.86-1.03],0.1570530558269036
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21698,252,0.97 [0.81-1.16],0.7566204022767593
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21608,162,1.10 [0.91-1.34],0.3351325070819846
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of intestine,18150,1354,0.96 [0.89-1.04],0.3142064134691174
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of intestines,21672,4876,0.98 [0.94-1.02],0.3607955430819594
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22612,197,1.04 [0.86-1.25],0.6848215939885768
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of liver,23350,564,0.92 [0.81-1.04],0.1873128719686906
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18126,499,0.98 [0.86-1.11],0.7270222252953868
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21576,130,0.94 [0.73-1.22],0.6660722838629596
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23382,392,0.96 [0.83-1.11],0.6143283429775446
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18546,919,1.03 [0.94-1.12],0.5505421932023953
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23068,960,0.95 [0.87-1.05],0.3161175299530306
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22786,149,0.89 [0.69-1.15],0.377626964439397
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18302,1506,0.97 [0.90-1.04],0.4320479246694602
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19423,1796,0.99 [0.92-1.05],0.668493589889213
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22873,87,1.18 [0.93-1.49],0.1714599260772428
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22656,821,0.99 [0.90-1.09],0.9146476895852788
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17082,286,0.90 [0.75-1.07],0.2351171756411694
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23453,64,0.98 [0.69-1.38],0.895999794240575
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17221,425,0.89 [0.77-1.04],0.1461095148824342
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22227,119,0.73 [0.52-1.02],0.0675497394687376
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23538,63,0.81 [0.53-1.24],0.3328689520229808
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22636,113,0.85 [0.62-1.15],0.2855624748310847
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Toxic colitis,21890,55,1.02 [0.72-1.45],0.893124275134779
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17835,208,0.88 [0.71-1.09],0.239351083602056
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ulcerative colitis,21982,147,0.67 [0.48-0.93],0.0152792563073862
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21959,124,0.61 [0.42-0.89],0.0103657179046339
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Umbilical hernia,20205,148,1.05 [0.84-1.30],0.6799598714977226
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16960,164,0.93 [0.74-1.17],0.5404447197671229
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ventral hernia,20272,215,0.99 [0.82-1.19],0.9000388024724431
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Volvulus,16868,72,1.00 [0.72-1.38],0.9891811704568918
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23471,216,0.93 [0.76-1.13],0.4647745714002099
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23269,77,0.72 [0.47-1.11],0.1340418662802615
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21794,196,1.16 [0.98-1.36],0.0758211582923005
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23078,543,0.96 [0.85-1.08],0.4887918547301704
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22662,127,1.09 [0.88-1.35],0.4336495079211167
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21875,277,0.94 [0.79-1.13],0.5249608595730686
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23271,240,1.01 [0.84-1.20],0.9446347642422848
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23449,418,1.06 [0.93-1.20],0.3850663669545824
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23075,44,1.10 [0.76-1.59],0.6075798182311305
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22182,2733,1.00 [0.95-1.06],0.8852909608365176
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23165,402,1.00 [0.87-1.14],0.9759325740539738
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23036,273,0.95 [0.80-1.13],0.5792069338664676
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23265,730,0.97 [0.88-1.08],0.582605788949327
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23528,66,0.97 [0.68-1.37],0.8587732230465469
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21686,88,1.12 [0.87-1.44],0.3788949109589955
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22804,41,1.19 [0.85-1.67],0.3198309826179276
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23257,226,1.01 [0.85-1.21],0.8961093293130856
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21957,359,0.90 [0.77-1.06],0.2065251045360837
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21643,45,0.75 [0.43-1.29],0.3001678303905364
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23457,68,1.14 [0.86-1.51],0.368944514025493
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22664,129,0.88 [0.67-1.16],0.3565469436900607
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23342,150,1.07 [0.87-1.32],0.500487678964019
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23074,43,1.18 [0.84-1.66],0.3376414274607917
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21654,56,0.75 [0.46-1.22],0.2437679160903873
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22969,1371,1.03 [0.96-1.11],0.3489615445550972
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21988,390,0.93 [0.80-1.09],0.3756149569315328
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21647,49,0.79 [0.48-1.30],0.3464335431490311
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23474,282,1.00 [0.85-1.18],0.9693854303617618
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23105,74,1.22 [0.95-1.55],0.1181280754443746
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23411,219,1.00 [0.83-1.20],0.9868441794700122
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23498,243,0.91 [0.75-1.10],0.3249891506567235
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21741,143,1.17 [0.97-1.41],0.0907465996405996
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21821,223,0.99 [0.82-1.19],0.8841566652446774
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23486,231,0.92 [0.76-1.12],0.406351720802697
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21768,170,0.86 [0.67-1.11],0.2463956377327487
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23514,125,1.11 [0.90-1.38],0.3363757321165885
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20085,116,1.06 [0.84-1.34],0.6147175823417164
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21374,5488,0.98 [0.95-1.02],0.3590048946922016
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20191,4305,0.99 [0.95-1.03],0.686186970532853
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20033,64,0.70 [0.43-1.12],0.1369587667886909
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20203,134,1.12 [0.92-1.38],0.266634196228978
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20247,178,0.99 [0.80-1.22],0.8970998939607271
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23298,101,1.09 [0.85-1.39],0.5177277465932132
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20169,100,0.82 [0.58-1.15],0.2459853289867432
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17077,1191,1.03 [0.96-1.11],0.437837317153073
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23410,200,0.98 [0.80-1.19],0.8403745139747756
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20567,498,0.98 [0.87-1.12],0.8119902771034548
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19768,6995,0.98 [0.95-1.01],0.2507128862828213
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21086,122,1.05 [0.83-1.33],0.6849726584837823
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20087,118,0.87 [0.65-1.16],0.3423385127831562
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20562,593,1.03 [0.92-1.15],0.6148917080026745
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22665,2596,1.02 [0.97-1.07],0.5171960264346195
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20121,152,0.92 [0.72-1.17],0.4933020060488698
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20300,331,0.98 [0.84-1.14],0.7697985880866347
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20120,151,1.13 [0.94-1.37],0.1850922859786209
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22690,94,0.67 [0.44-1.01],0.0531280090704047
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17516,1630,0.94 [0.87-1.01],0.0815144451544668
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16064,178,1.00 [0.81-1.23],0.972557209591502
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23533,175,1.03 [0.85-1.26],0.7496744001114781
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15975,89,1.07 [0.82-1.39],0.6410296353341706
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16383,497,0.92 [0.81-1.06],0.2545630720064961
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20257,288,0.95 [0.80-1.13],0.5666360792025174
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16442,556,0.92 [0.81-1.05],0.223643730400054
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20126,57,1.09 [0.78-1.51],0.6185250009240284
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20689,620,1.05 [0.95-1.16],0.3560353722027998
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20358,289,1.01 [0.86-1.19],0.870942160811255
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16402,516,0.89 [0.77-1.02],0.0875956632779178
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20042,73,1.13 [0.86-1.49],0.3915060472932097
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20027,58,1.26 [0.97-1.63],0.0784419265330171
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21007,43,0.99 [0.65-1.52],0.9609394410704388
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23136,2172,1.03 [0.97-1.09],0.3252624597396546
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22527,1563,1.03 [0.96-1.10],0.456607306930639
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23368,517,1.06 [0.95-1.18],0.3299124302976008
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18518,2632,1.02 [0.96-1.07],0.5557809313420993
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15946,60,0.91 [0.62-1.35],0.6430177148621019
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20057,88,0.93 [0.68-1.28],0.6700504557115359
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15927,41,0.87 [0.53-1.43],0.5807772956153097
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16065,179,0.98 [0.79-1.20],0.8213393815345202
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21223,259,1.11 [0.95-1.29],0.1969624922350115
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21450,486,0.99 [0.87-1.12],0.8173713688807442
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23522,92,0.81 [0.56-1.15],0.2330108238258338
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21828,1759,1.01 [0.94-1.07],0.8510472021378497
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20081,112,1.10 [0.87-1.38],0.4246144190291794
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16092,206,0.79 [0.62-1.00],0.0521027433386795
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20767,698,1.02 [0.92-1.13],0.7289289367335545
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18080,2194,0.97 [0.91-1.03],0.2941365208999125
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22708,112,0.66 [0.46-0.97],0.0323887568276565
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23529,75,0.73 [0.48-1.12],0.149397300275794
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20035,66,1.11 [0.83-1.48],0.5000785270408266
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21239,1270,0.98 [0.90-1.06],0.5699410075555731
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20041,72,0.79 [0.53-1.19],0.258712967157484
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17595,1709,0.96 [0.90-1.03],0.2876710939162614
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21091,127,1.09 [0.88-1.36],0.4298269761816473
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20016,47,1.12 [0.80-1.57],0.5238206476072532
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20243,174,0.85 [0.66-1.09],0.2001878459838511
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20474,505,0.97 [0.86-1.10],0.6792316437676504
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23042,446,1.02 [0.90-1.16],0.7284074902749553
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20624,555,0.98 [0.87-1.10],0.7138583397020293
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23378,499,1.07 [0.95-1.19],0.2607600069744031
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23520,58,0.96 [0.66-1.39],0.8218429578502899
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20160,191,0.99 [0.81-1.21],0.9215653920728544
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18052,780,1.00 [0.91-1.10],0.9905836567505056
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20537,568,0.99 [0.88-1.11],0.8392191893484697
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20071,102,0.77 [0.54-1.09],0.1441457216763986
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15958,72,1.16 [0.89-1.51],0.2857717981842916
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18165,2279,0.98 [0.92-1.04],0.5100271591128338
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16611,725,0.96 [0.86-1.07],0.4844064915801549
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22849,253,0.93 [0.77-1.12],0.4606955508859317
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23498,68,0.88 [0.60-1.29],0.5112426512768989
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21555,47,0.87 [0.55-1.37],0.5418020446706326
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15962,76,0.75 [0.50-1.14],0.1748140608224233
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20167,98,1.02 [0.78-1.34],0.8935116653538471
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16407,521,1.04 [0.93-1.17],0.4735118326682845
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20246,277,1.03 [0.88-1.21],0.686584812519625
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20313,244,0.89 [0.72-1.09],0.24335547769905
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20308,239,0.96 [0.80-1.16],0.663761149816847
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18144,77,1.03 [0.77-1.39],0.8449441058718905
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23526,64,0.93 [0.64-1.34],0.6893438402588259
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20517,548,1.03 [0.92-1.15],0.642836232483082
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22745,149,1.11 [0.91-1.35],0.307834330127871
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22399,2430,0.98 [0.93-1.04],0.5301117951012382
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20103,134,0.79 [0.59-1.07],0.1292080373089011
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20543,474,0.99 [0.87-1.12],0.8303169827516663
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22027,225,0.91 [0.75-1.12],0.3849057101508853
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20279,210,1.04 [0.87-1.24],0.6732428175421898
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21552,1483,1.01 [0.95-1.09],0.6910675470196816
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21076,1007,1.01 [0.92-1.10],0.8940596287442182
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20024,55,0.86 [0.56-1.33],0.5002523445014371
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22808,212,1.13 [0.96-1.33],0.1310439533995166
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20142,173,0.94 [0.75-1.17],0.5879064594179878
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20082,113,0.78 [0.56-1.09],0.1428028917107971
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15930,44,0.93 [0.59-1.46],0.7460509915146163
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22719,1027,1.05 [0.97-1.14],0.2031769440697634
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17606,86,0.99 [0.74-1.33],0.9488143334608397
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22949,98,1.04 [0.80-1.35],0.7764108726123993
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23410,196,0.99 [0.81-1.21],0.933163186973075
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23236,22,0.80 [0.38-1.66],0.543224458755454
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22834,1142,1.01 [0.93-1.09],0.8324128063953238
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23407,58,0.93 [0.63-1.38],0.7257675392159153
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23376,199,0.91 [0.74-1.13],0.4100412335584061
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Cystitis,20807,215,1.18 [1.02-1.37],0.0297914288553211
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Dialysis,21735,43,0.95 [0.61-1.49],0.8317938845914107
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23131,280,1.01 [0.86-1.18],0.930163978423804
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Endometriosis,17668,148,0.84 [0.64-1.09],0.1895092319226461
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17861,341,0.97 [0.84-1.13],0.7096523539792214
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18383,863,0.92 [0.83-1.02],0.1167155884538821
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18308,4247,0.99 [0.95-1.03],0.647882761342726
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23399,50,1.03 [0.71-1.50],0.8647711072415237
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21571,181,1.01 [0.83-1.24],0.9056276990557218
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23077,343,1.04 [0.90-1.19],0.6212727349851148
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Irregular menses,23150,110,1.09 [0.87-1.37],0.4592412581535895
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17787,267,0.98 [0.83-1.16],0.8395102494618341
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20656,64,0.92 [0.63-1.34],0.6557547228035101
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19624,2104,0.97 [0.91-1.03],0.2843243551930682
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17638,118,1.04 [0.82-1.32],0.7468786308450805
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23537,57,0.96 [0.66-1.40],0.8336652276147596
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23537,67,1.26 [0.99-1.61],0.0633694208239274
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22478,1886,1.01 [0.95-1.08],0.7380024706417851
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20997,405,0.88 [0.75-1.03],0.1079125132310016
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22951,100,1.08 [0.85-1.39],0.5199540361229934
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23496,319,1.06 [0.92-1.23],0.3904980176628646
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23494,74,1.00 [0.72-1.37],0.983894009083618
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22204,1612,1.03 [0.96-1.10],0.4631974042108541
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22912,178,0.98 [0.79-1.21],0.8463016606952689
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17656,136,1.09 [0.89-1.34],0.4170219441133577
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17858,338,1.12 [0.99-1.28],0.0778298367221726
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17621,101,1.00 [0.76-1.31],0.990527157169482
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17696,176,1.09 [0.91-1.31],0.3369284113100296
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21615,225,0.98 [0.81-1.18],0.8320970581635241
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23282,105,1.29 [1.07-1.55],0.0073840420441587
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17783,263,0.98 [0.83-1.16],0.8194147677164356
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17610,90,0.76 [0.52-1.10],0.1432116544179122
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18073,553,1.04 [0.94-1.16],0.4472236931066541
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17656,136,0.99 [0.78-1.26],0.9461231327145846
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18026,506,1.06 [0.94-1.18],0.3352906873875025
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23382,33,1.35 [1.00-1.84],0.051532684683301
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23395,2005,1.02 [0.96-1.08],0.4986533447205904
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21538,148,0.89 [0.69-1.15],0.3657719575225384
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21772,80,1.27 [1.02-1.59],0.0319661262579342
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23242,28,1.19 [0.79-1.80],0.4101873039423506
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20719,127,0.56 [0.38-0.83],0.0036233105119222
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23437,223,1.01 [0.84-1.21],0.9425170123595028
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17638,118,0.79 [0.58-1.09],0.1473314162811741
